2.16
前日終値:
$2.22
開ける:
$2.2
24時間の取引高:
395.55K
Relative Volume:
0.04
時価総額:
$34.74M
収益:
$1.38M
当期純損益:
$-179.05M
株価収益率:
-0.3518
EPS:
-6.14
ネットキャッシュフロー:
$-155.03M
1週間 パフォーマンス:
-12.00%
1か月 パフォーマンス:
-12.35%
6か月 パフォーマンス:
+28.10%
1年 パフォーマンス:
+273.65%
Bioxcel Therapeutics Inc Stock (BTAI) Company Profile
名前
Bioxcel Therapeutics Inc
セクター
電話
203-643-8060
住所
555 LONG WHARF DRIVE, NEW HAVEN, CT
BTAI を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
BTAI
Bioxcel Therapeutics Inc
|
2.1698 | 43.22M | 1.38M | -179.05M | -155.03M | -6.14 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
425.96 | 109.29B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
463.17 | 62.13B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
573.82 | 61.40B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
815.09 | 51.39B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
308.21 | 34.68B | 4.56B | -176.77M | 225.30M | -1.7177 |
Bioxcel Therapeutics Inc Stock (BTAI) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-02-21 | ダウングレード | UBS | Buy → Neutral |
2023-08-15 | ダウングレード | Mizuho | Buy → Neutral |
2023-07-17 | ダウングレード | Guggenheim | Buy → Neutral |
2023-03-10 | ダウングレード | Jefferies | Buy → Hold |
2022-12-01 | アップグレード | Goldman | Sell → Neutral |
2022-07-07 | 開始されました | Mizuho | Buy |
2022-04-06 | 繰り返されました | BofA Securities | Buy |
2021-11-15 | ダウングレード | Goldman | Neutral → Sell |
2021-04-09 | 開始されました | Berenberg | Buy |
2021-02-01 | 開始されました | UBS | Buy |
2020-10-30 | 開始されました | Goldman | Buy |
2020-09-02 | 開始されました | Jefferies | Buy |
2020-08-17 | 繰り返されました | H.C. Wainwright | Buy |
2020-07-08 | 繰り返されました | H.C. Wainwright | Buy |
2020-06-04 | 開始されました | Guggenheim | Buy |
2020-04-01 | 開始されました | BofA/Merrill | Buy |
2020-02-26 | 繰り返されました | H.C. Wainwright | Buy |
2020-01-08 | 繰り返されました | H.C. Wainwright | Buy |
2019-11-12 | 開始されました | SunTrust | Buy |
すべてを表示
Bioxcel Therapeutics Inc (BTAI) 最新ニュース
Why BioXcel Therapeutics Inc. stock could see breakout soonPrice Action & Reliable Entry Point Trade Alerts - newser.com
Building trade automation scripts for BioXcel Therapeutics Inc.Portfolio Value Report & Stepwise Swing Trade Plans - newser.com
Published on: 2025-10-23 02:55:59 - newser.com
Key metrics from BioXcel Therapeutics Inc.’s quarterly dataInsider Buying & Expert Verified Stock Movement Alerts - newser.com
Will BioXcel Therapeutics Inc. benefit from macro trendsJuly 2025 Movers & Technical Pattern Based Buy Signals - newser.com
Will BioXcel Therapeutics Inc. (BX20) stock recover faster than industryMarket Rally & Weekly Breakout Opportunity Watchlist - newser.com
How BioXcel Therapeutics Inc. (BX20) stock reacts to stronger dollarJuly 2025 PostEarnings & Free Real-Time Volume Trigger Notifications - newser.com
BioXcel Therapeutics Inc. stock chart pattern explainedJuly 2025 Volume & Free Community Consensus Stock Picks - newser.com
How analysts revise price targets for BioXcel Therapeutics Inc. (BX20) stockGold Moves & AI Enhanced Trading Signals - newser.com
Sentiment analysis tools applied to BioXcel Therapeutics Inc.July 2025 Retail & Reliable Price Breakout Alerts - newser.com
Published on: 2025-10-20 19:22:51 - newser.com
Published on: 2025-10-20 07:46:17 - newser.com
Strategies to average down on BioXcel Therapeutics Inc.July 2025 Patterns & Community Consensus Trade Alerts - newser.com
Is BioXcel Therapeutics Inc. stock supported by strong fundamentalsQuarterly Trade Summary & Daily Profit Focused Stock Screening - nchmf.gov.vn
Is BioXcel Therapeutics Inc. stock a smart buy before Fed meetingJuly 2025 Volume & Short-Term Trading Alerts - nchmf.gov.vn
How BioXcel Therapeutics Inc. (BX20) stock responds to bond marketWeekly Gains Report & Community Consensus Picks - nchmf.gov.vn
Aug EndMonth: Will BioXcel Therapeutics Inc. stock recover faster than peers2025 Technical Patterns & Weekly Breakout Stock Alerts - nchmf.gov.vn
BioXcel Therapeutics, Inc.Common Stock (NQ: BTAI - FinancialContent
Published on: 2025-10-18 01:05:28 - nchmf.gov.vn
Why BioXcel Therapeutics Inc. (BX20) stock is a must watch tickerJuly 2025 Short Interest & Stepwise Trade Execution Plans - nchmf.gov.vn
BioXcel stock rating reiterated at Buy by H.C. Wainwright on trial results - Investing.com Canada
BioXcel Therapeutics IncNo Serious Adverse Events Reported in Study - 富途牛牛
Will BioXcel Therapeutics Inc. stock recover faster than peersMarket Activity Summary & Trade Opportunity Analysis - newser.com
BioXcel Therapeutics Rings the Nasdaq Stock Market Closing Bell - Nasdaq
BioXcel Therapeutics Rings the Closing Bell - Nasdaq
BioXcel Therapeutics (BTAI) Reports Positive Study Results Suppo - GuruFocus
BioXcel reports positive correlation study results for BXCL501 By Investing.com - Investing.com Nigeria
Bioxcel Therapeutics Inc (BTAI) 財務データ
収益
当期純利益
現金流量
EPS
Bioxcel Therapeutics Inc (BTAI) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Mehta Vimal | CEO and President |
Dec 16 '24 |
Sale |
0.36 |
3,117 |
1,131 |
59,605 |
Steinhart Richard I | Chief Financial Officer |
Dec 16 '24 |
Sale |
0.36 |
577 |
207 |
20,932 |
Rodriguez Javier | See Remarks |
Dec 16 '24 |
Sale |
0.36 |
430 |
153 |
24,423 |
Yocca Frank | Chief Scientific Officer |
Dec 16 '24 |
Sale |
0.35 |
430 |
152 |
28,931 |
大文字化:
|
ボリューム (24 時間):